SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis.

作者信息

Lehmann Ulrich, Bartels Stephan, Hasemeier Britta, Geffers Robert, Schlue Jerome, Büsche Guntram, Hussein Kais, Kreipe Hans

出版信息

Blood. 2013 May 9;121(19):4011-2. doi: 10.1182/blood-2012-11-467662.

DOI:10.1182/blood-2012-11-467662

PMID:23660863

Abstract

摘要

相似文献

SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis.

Blood. 2013 May 9;121(19):4011-2. doi: 10.1182/blood-2012-11-467662.

SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation.

Leukemia. 2015 Jan;29(1):253-5. doi: 10.1038/leu.2014.277. Epub 2014 Sep 18.

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival.

Blood. 2012 Nov 15;120(20):4168-71. doi: 10.1182/blood-2012-05-429696. Epub 2012 Sep 11.

Mutations and prognosis in primary myelofibrosis.

Leukemia. 2013 Sep;27(9):1861-9. doi: 10.1038/leu.2013.119. Epub 2013 Apr 26.

The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.

Hum Pathol. 2014 Dec;45(12):2471-9. doi: 10.1016/j.humpath.2014.08.014. Epub 2014 Sep 7.

Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations.

Blood Cancer J. 2016 Apr 8;6(4):e415. doi: 10.1038/bcj.2016.22.

U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype.

Leukemia. 2014 Feb;28(2):431-3. doi: 10.1038/leu.2013.286. Epub 2013 Oct 7.

Screening for ASXL1 and SRSF2 mutations is imperative for treatment decision-making in otherwise low or intermediate-1 risk patients with myelofibrosis.

Br J Haematol. 2018 Nov;183(4):678-681. doi: 10.1111/bjh.15010. Epub 2017 Nov 23.

[SRSF2 mutation in patients with chronic myelomonocytic leukemia].

Zhonghua Xue Ye Xue Za Zhi. 2013 Dec;34(12):1024-7. doi: 10.3760/cma.j.issn.0253-2727.2013.12.006.

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.

Blood. 2012 Apr 12;119(15):3578-84. doi: 10.1182/blood-2011-12-399337. Epub 2012 Mar 2.

引用本文的文献

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2.

Leukemia. 2018 Feb;32(2):556-558. doi: 10.1038/leu.2017.298. Epub 2017 Sep 22.

Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.

Oncotarget. 2016 May 24;7(21):30084-93. doi: 10.18632/oncotarget.8310.

[Diagnostic molecular pathology of lymphatic and myeloid neoplasms].

Pathologe. 2015 Mar;36(2):164-70. doi: 10.1007/s00292-015-0007-1.

SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation.

Leukemia. 2015 Jan;29(1):253-5. doi: 10.1038/leu.2014.277. Epub 2014 Sep 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验